The objective of the study is to compare the efficacy of weekly GrafixPRIME® administration to an Active Comparator in patients with chronic DFUs in a randomized, single-blind study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
75
Human tissue, Wound cover, Application of a non-adherent dressing, a moisture retentive dressing, and a secondary dressing.
Wound cover, Application of a non-adherent dressing, a moisture retentive dressing, and a secondary dressing.
Patients will be fitted for an off-loading device (walking boot) and agree to comply with use of the device during the course of the study
Unnamed facility
Arizona City, Arizona, United States
Unnamed facility
California City, California, United States
Unnamed facility
New Mexico, New Mexico, United States
Complete closure of index wound
Time frame: Up to Day 56
Time to wound closure
Time frame: Up to Day 56
Proportion of patients that achieve a 50% reduction or greater in wound size
Time frame: Day 28
Number of product applications
Time frame: Up to Day 56
Number of Adverse Events
Time frame: Up to Day 56
Number of patients with worsening of wound by ≥50% increase in size
Time frame: Up to Day 56
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.